Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/1/10 → 06/1/23 |
Funding
- Actelion Clinical Research Incorporated: $108,448.75
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Three Doses of ACT-128800, an Oral S1P1 Receptor Agonist, Administered for Twenty-Four Weeks
- Coyle, Patricia K (PI)
- Krupp, Lauren (CoPI)
- Melville, Patricia (CoPI)
Project: Research